Metraipolis › archive › dc_ce7c463c033b

Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease — Europe PMC PMID:42325216

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42325216
DOI
10.14740/gr2136
License (as archived)
solo-consultazione
Archived
2026-10-19T09:25:12.739Z
SHA-256 of the archived text
973378f7b7cf571d0a824d3a375aa28ac0bdc15d4057dba6154b5d3a49a2a31a
Stable URL of this page
https://metraipolis.com/documento/dc_ce7c463c033b

How to cite

Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease — Europe PMC PMID:42325216 — Europe PMC (en), https://europepmc.org/article/MED/42325216 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce7c463c033b (Metraipolis archive dc_ce7c463c033b, sha256 973378f7b7cf571d0a824d3a375aa28ac0bdc15d4057dba6154b5d3a49a2a31a)
BibTeX
@misc{dcce7c463c033b,
  title = {Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease — Europe PMC PMID:42325216},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42325216},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce7c463c033b; sha256 973378f7b7cf571d0a824d3a375aa28ac0bdc15d4057dba6154b5d3a49a2a31a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42325216. Agents can read the archived copy with the MCP tool read_document.